For the nine months ended September 30, 2022, we had net income of $6,668,726, which resulted from a gain on the change in fair value of warrant liabilities of $6,574,333, unrealized gain on investments held in Trust Account of $1,378,078, a change in fair value of convertible note of $3,000, and interest income of $10, partially offset by operating and formation costs of $915,566, income tax expense of $221,839 and franchise tax expense of $149,290.
For the period from January 12, 2021 (Inception) through September 30, 2021, we had net income of $10,382,310, which resulted from a gain on the change in fair value of warrant liabilities of $11,833,800, unrealized gain on investments held in Trust Account of $14,017, dividend income of $4,265, and interest income of $48, partially offset by expensed offering costs of $686,818, loss on sale of private placement warrants of $224,333, operating and formation costs of $419,325, and franchise tax expense of $139,344.
Liquidity and Capital Resources
On March 23, 2021, we consummated an Initial Public Offering of 22,400,000 units generating gross proceeds of $224,000,000. Simultaneously with the consummation of the Initial Public Offering, we completed the private sale of 4,486,667 private placement warrants to the Sponsor at a purchase price of $1.50 per warrant, generating gross proceeds of $6,730,000.
For the nine months ended September 30, 2022, net cash used in operating activities was $953,844, which was due to a gain on the change in fair value of warrant liabilities of $6,574,333, unrealized gains on investments held in Trust Account of $1,378,078, and a gain on change in fair value of convertible promissory note - related party of $3,000, partially offset by our net income of $6,668,726 and changes in working capital of $332,841.
For the period from January 12, 2021 (Inception) through September 30, 2021, net cash used in operating activities was $724,407, which was due to a gain on the change in fair value of warrant liabilities of $11,833,800, changes in working capital of $165,786, unrealized gains on investments held in Trust Account of $14,017, and dividend income of $4,265, partially offset by our net income of $10,382,310, expensed offering costs of $686,818, and the loss on sale of private placement warrants of $224,333.
For the nine months ended September 30, 2022, net cash provided by investing activities was $39,393, which was due to proceeds from the Trust Account to pay taxes of $39,393.
For the period from January 12, 2021 (Inception) through September 30, 2021, net cash used in investing activities was $224,000,000, which was due to cash deposited in the Trust Account as a result of gross proceeds of the Public Offering.
For the nine months ended September 30, 2022, net cash flows from financing activities were due to proceeds from convertible promissory note - related party of $200,000.
For the period from January 12, 2021 (Inception) through September 30, 2021, net cash provided by financing activities was $225,648,180, which was due to proceeds from the Initial Public Offering, net of cash underwriter’s discount paid, of $219,520,000, proceeds from the sale of private placement warrants of $6,730,000, proceeds from the issuance of a promissory note to our Sponsor of $125,000, and proceeds from the issuance of Class B common stock to our Sponsor of $25,000, partially offset by payments of offering costs of $626,820 and the prepayment of the promissory note with our Sponsor of $125,000.
As of September 30, 2022, we had cash of $66,851 held outside the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.